← Open Payments lookup

THOMAS SHOAF: Open Payments

NPI 1396031027 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$29,975 in 157 payments from 22 companies in 2025. Trend: 2023 $2,619 · 2024 $1,941 · 2025 $29,975

Debt forgiveness: $27,090Food & beverage: $2,885
CompanyPaymentsAmount
Neuronetics, Inc.1$27,090
Vanda Pharmaceuticals Inc.22$557
Neurocrine BioSciences, Inc.18$310
ABBVIE INC.24$303
Alkermes, Inc.15$202
Validus Pharmaceuticals LLC9$195
Otsuka America Pharmaceutical, Inc.10$194
E.R. Squibb & Sons, L.L.C.11$183
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$163
Teva Pharmaceuticals USA, Inc.7$160

Products named: NEUROSTAR TMS THERAPY SYSTEM, FANAPT, INGREZZA, VRAYLAR, REXULTI, COBENFY, CAPLYTA, Azstarys.

Industry payments across TX — which companies pay providers there.